Intrinsic Value of S&P & Nasdaq Contact Us

Monopar Therapeutics Inc. MNPR NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$121.00
+108.9%

Monopar Therapeutics Inc. (MNPR) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRV, ACXP, ADAG, ANEB, ANTX, AVTE and others.

MNPR has a market capitalization of $387.61M, compared to an average peer market cap of $252.42M. MNPR is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message